Heparin-induced thrombotic thrombocytopenia

Area of Science:

• Vascular Medicine
• Hematology
• Pharmacology

Background:

• Subcutaneous heparin administration is a common anticoagulant therapy.
• Vascular complications following heparin treatment are a recognized concern.
• Understanding heparin-induced adverse events is crucial for patient safety.

Observation:

• A patient developed severe vascular occlusion in both legs after subcutaneous heparin therapy.
• Thrombocytopenia (low platelet count) was observed in the patient.
• In vitro studies showed heparin-induced platelet aggregation.

Findings:

• The patient's clinical presentation was consistent with heparin-induced thrombocytopenia and thrombosis (HITT).
• Heparin directly triggered platelet activation and aggregation in the affected patient.
• The syndrome involves a paradoxical prothrombotic state induced by heparin.

Implications:

• Early recognition of HITT is critical to prevent limb-threatening ischemia and systemic thrombosis.
• Alternative anticoagulation strategies are necessary for patients with heparin-induced complications.
• This case highlights the importance of vigilant monitoring for adverse reactions to heparin therapy.